Cincinnati children's research paves way for newly approved asthma drug

(Cincinnati Children's Hospital Medical Center) Thanks in part to nearly two decades of research at Cincinnati Children's Hospital Medical Center, the FDA has approved benralizumab, the first drug designed to specifically deplete eosinophils as a treatment for asthma.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news